2026 Post Meeting Report

DOWNLOAD POST MEETING REPORT

1 622

registered participants

958

delegates

664 speakers / poster presenters
including
259 faculty members

52%

Western Europe

17.6%

Eastern Europe

13.9%

North America
(only Canada + USA)

10%

Asia / Oceania

5.2%

Latin America
(including Mexico + Carribean)

1.3%

Africa

Program Structure

90+

sessions

33 Scientific Sessions

9 Clinical Sessions

5 Artificial Intelligence Sessions

10 HPV & Head and Neck Forum Sessions

4 Specialized Workshops

1 Full-day German-speaking Workshop

1 Full-day Central and Eastern Europe Workshop

29 Free Communications Sessions

725

presentations

103

posters

5

industry sponsored
satellite symposia

The EUROGIN 2026 congress has been assessed as fully compliant by EthicalMedTech.

EUROGIN complies with the highest ethical standards certified by Ethical MedTech Europe Code of Ethical Business Practice. Ethical MedTech Europe enforces strict regulations to authenticate the relevance, ethics, and integrity of educational events in the healthcare sector in correlation with the MedTech Europe Code.

Event reference: EMT-25-0708

Sponsors & Exhibitors

30

exhibitors

300m²

of exhibits

4.18
average rating

Meet current
clients / partners

3.97
average rating

Brand(s) / Products /
Services awareness

3.95
average rating

Find new partners

3.83
average rating

Generate
new sales leads

Delegates Feedback Survey

Global Overview

4.4 average rating

Overall conference

8 out of 10

Attendees likely to return

4.3 average rating

Importance to attend

Best Aspects

4.55
average rating

Scientific program /
Content's quality

4.56
average rating

Speakers

4.22
average rating

Interaction's ability
Exhibitors / Sponsors

4.15
average rating

Networking opportunities

Testimonials

“

There’s something special about being surrounded by people who are so passionate about improving cancer screening, prevention and early diagnosis - it’s energising, motivating, and a great reminder of why this work matters.

”

“

An outstanding congress, as always. Grateful to have contributed and leaving inspired, with new ideas, collaborations, and projects ahead.
Looking forward to next year!

”

“

It was my first HPV-focused congress in quite some time, and it reminded me that science never stands still. From the integration of AI, to shifts in HPV genotype prevalence [...] EUROGIN 2026 was a powerful learning experience.

”

Newsletter Sign up

Be the first to receive updates on our upcoming program and workshops, speakers, special rates and more! Let’s stay in touch!

KEEP ME INFORMED